Atossa Therapeutics
ATOS
ATOS
83 hedge funds and large institutions have $17.7M invested in Atossa Therapeutics in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
–
Holders Change %
0%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
13
Reduced
23
Closed
28
Calls
$174K
Puts
$91K
Net Calls
+$83K
Net Calls Change
+$18K
Top Buyers
| 1 |
1
Ameriprise
Minneapolis,
Minnesota
|
$2.47M |
| 2 |
2
Millennium Management
New York
|
$1.7M |
| 3 |
3
Jane Street
New York
|
$381K |
| 4 |
YIH
4
Y-Intercept (HK)
Hong Kong
|
$321K |
| 5 |
5
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$346K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$1.78M |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$1.08M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$429K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$4.84M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$219K |
